Mutation in RNF213 was found in 95% of patients with familial MMD, 73% of patients with non-familial MMD, and 1.4% of controls.[8] After these discoveries, research focusing on the biological effect of mutant RNF213 has progressed. This evidence concerns the gene RNF213 and multiminicore myopathy.